Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis
dc.contributor.author | Tasdogan, Muhittin | |
dc.contributor.author | Memis, Dilek | |
dc.contributor.author | Sut, Necdet | |
dc.contributor.author | Yuksel, Mahmut | |
dc.date.accessioned | 2024-06-12T10:50:14Z | |
dc.date.available | 2024-06-12T10:50:14Z | |
dc.date.issued | 2009 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Study Objective: To compare the effects of an intravenous infusion of propofol and the alpha-2 adrenoceptor, dexmedetomidine, on inflammatory responses and intraabdominal pressure (LAP) in severe sepsis after abdominal surgery, specifically, serum cytokine levels (interleukin [IL]-1, IL-6, and tumor necrosis factor [TNF]-alpha) and IAP. Design: Prospective, single-center study. Setting: University hospital. Patients: 40 adult ICU patients who had undergone ileus surgery and who were expected to require postoperative sedation and ventilation. Interventions: Patients received either a loading dose infusion of propofol (Group P; n = 20) one mg/kg over 15 minutes followed by a maintenance dose of one to three mg/kg/hr (n = 20, Group P) or a loading dose of dexmedetomidine of one mu g/kg over 10 minutes followed by a maintenance dose of 0.2-2.5 mu g/kg/h (n = 20, Group D) at the 24th hour. Measurements: Biochemical and hemodynamic parameters, cytokine levels, and IAP were recorded before the start of the study and at the 24th and 48th hours. Main Results: TNF-alpha levels were significantly lower at the 24th hour (14.66 +/- 4.40 pg/mL vs. 21.21 +/- 11.37 pg/mL, respectively) and at the 48th hour (21.25 +/- 15.85 pg/mL vs. 46.55 +/- 35.99 pg/mL, respectively) in Group D. IL-1 levels were significantly lower at the 24th hour (5.03 +/- 0.15 pg/mL vs. 6.23 +/- 2.09 pg/mL, respectively) and the 48th hour (5.01 +/- 0.37 pg/mL vs. 6.42 +/- 2.76 pg/mL, respectively) in Group D. IL-6 levels were significantly lower at the 24th hour (253.1 +/- 303.6 pg/mL and 511.3 +/- 374.8 pg/mL, respectively) and at the 48th hour (343.5 +/- 393.4 pg/rnL and 503.7 +/- 306.4 pg/mL, respectively) in Group D. Intraabdominal pressure also was significantly lower at the 24th hour (12.35 +/- 5.84 mmHg vs, 18.1 +/- 2.84 mmHg, respectively) and the 48th hour (13.9 +/- 6.15 mmHg vs. 18.7 +/- 3.46 mmHg, respectively) in Group D. Conclusion: Dexmedetomidine infusion decreases TNF-a, IL-1, and IL-6 levels and IAP more than a propofol infusion. (C) 2009 Elsevier Inc. All rights reserved. | en_US |
dc.description.sponsorship | University of Trakya Research, Edime, Turkey [TUBAP 666] | en_US |
dc.description.sponsorship | Supported by University of Trakya Research Grant No. TUBAP 666, Edime, Turkey. | en_US |
dc.identifier.doi | 10.1016/j.jclinane.2008.10.010 | |
dc.identifier.endpage | 400 | en_US |
dc.identifier.issn | 0952-8180 | |
dc.identifier.issn | 1873-4529 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 19833271 | en_US |
dc.identifier.scopus | 2-s2.0-70349742451 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 394 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jclinane.2008.10.010 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/17925 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | WOS:000271112400002 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Journal Of Clinical Anesthesia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Abdominal Surgery | en_US |
dc.subject | Cytokine Levels | en_US |
dc.subject | Dexmedetomidine | en_US |
dc.subject | Inflammatory Response | en_US |
dc.subject | Intraabdominal Pressure | en_US |
dc.subject | Propofol | en_US |
dc.subject | Severe Sepsis | en_US |
dc.subject | Abdominal Compartment Syndrome | en_US |
dc.subject | Induced Muscular Rigidity | en_US |
dc.subject | Critically-Ill | en_US |
dc.subject | International-Conference | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Involvement | en_US |
dc.subject | Pain | en_US |
dc.subject | Multicenter | en_US |
dc.subject | Validation | en_US |
dc.subject | Midazolam | en_US |
dc.title | Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis | en_US |
dc.type | Article | en_US |